DG
ORGS

Delek Group’s Orgenesis Inc. Common Stock ORGS Stock Holding History

Delek Group’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$278K Buy
+6,400
New +$289K 0.01% 202

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VCM
Venator Capital Management Toronto, Ontario, Canada $48.7M AUM 87.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GHA
GW Henssler & Associates Kennesaw, Georgia $2.12B AUM 20.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TFGT
TS Financial Group (TSFG) Lake Forest, Illinois $659M AUM 18.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Delek Group's ORGS Position: Q2 2019 in Review

Delek Group opened a new position in Orgenesis Inc. Common Stock (ORGS) in Q2 2019: 6,400 shares worth $278K. The stake represents 0.01% of the portfolio and ranks #202 among its holdings.

16 funds tracked by Wall St. Rank hold ORGS as of Q2 2019.

  • Delek Group held 6,400 shares of Orgenesis Inc. Common Stock worth $278K as of Q2 2019.
  • Orgenesis Inc. Common Stock was a new Delek Group position in Q2 2019.
  • Orgenesis Inc. Common Stock made up 0.01% of Delek Group's portfolio in Q2 2019, its #202 holding.
  • 16 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q2 2019.

Based on Delek Group's 13F filing for Q2 2019, filed 8 Aug 2019.